**5. Oral miltefosine**

This drug [4] is a derivative of alkyl phosphocholine with potent activity against leishmaniasis. It is the FDA-approved drug for the treatment of mucosal and visceral leishmaniasis due to *L. braziliensis, Leishmania guyanensis, and Leishmania panamensis.*

**Dose** (**Table 3**).

Available as 10 and 50 mg capsules.

Dose-1.5 to 2.5 mg/kg/day for 28 days orally up to 150 mg/day.

